Xellar Biosystems Overview
- Year Founded
-
2021
- Status
-
Private
- Employees
-
21
- Latest Deal Type
-
Series A2
- Investors
-
15
Xellar Biosystems General Information
Description
Developer of a biotechnology research tool designed to accelerate drug discovery and development. The company's platform offers artificial intelligence driven modeling, machine learning integration, and wet lab experimental capabilities, enabling pharmaceutical researchers and biotechnology firms to streamline compound identification and improve therapeutic development efficiency.
Contact Information
Website
www.xellarbio.comCorporate Office
- Shanghai Building 10 Number 6055 Jinhai Highway
- Fengxian District
- Shanghai, 100000
- China
Corporate Office
- Shanghai Building 10 Number 6055 Jinhai Highway
- Fengxian District
- Shanghai, 100000
- China
Xellar Biosystems Timeline
Xellar Biosystems Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Later Stage VC (Series A2) | 17-Nov-2026 | Completed | Generating Revenue | |||
| 5. Early Stage VC (Series A1) | 29-Jun-2026 | Completed | Generating Revenue | |||
| 4. Early Stage VC (Series A) | 01-Apr-2026 | Completed | Generating Revenue | |||
| 3. Early Stage VC | 27-Apr-2025 | Completed | Generating Revenue | |||
| 2. Early Stage VC | 16-Jul-2024 | $13.8M | $23.8M | Completed | Generating Revenue | |
| 1. Seed Round | 29-Aug-2022 | $10M | $10M | Completed | Startup |
Xellar Biosystems Comparisons
Industry
Financing
Details
Xellar Biosystems Competitors (39)
One of Xellar Biosystems’s 39 competitors is Genesis Molecular AI, a Venture Capital-Backed company based in San Mateo, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Genesis Molecular AI | Venture Capital-Backed | San Mateo, CA | ||||
| Asimov | Venture Capital-Backed | Boston, MA | ||||
| Exscientia | Formerly VC-backed | Oxford, United Kingdom | ||||
| A-Alpha Bio | Venture Capital-Backed | Seattle, WA | ||||
| X-37 | Venture Capital-Backed | South San Francisco, CA |
Xellar Biosystems Patents
Xellar Biosystems Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2025212883-A1 | Systems and methods for controlling perfusion within microfluidic devices | Pending | 03-Apr-2024 | ||
| WO-2024072514-A1 | Edge effect systems and methods for functionalized microfluidic devices | Inactive | 30-Sep-2022 | ||
| WO-2024072512-A1 | Methods and systems for functionalizing surfaces for microfluidic devices or other applications | Inactive | 30-Sep-2022 | ||
| WO-2024072511-A1 | Microfluidic devices containing hydrogels, and techniques for making and using | Inactive | 30-Sep-2022 | ||
| WO-2024072513-A1 | Pipette interface systems and methods for viscous fluid injection | Inactive | 30-Sep-2022 | G01N1/36 |
Xellar Biosystems Signals
Xellar Biosystems Investors (15)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Shanghai Guofang Private Equity Fund Management | Growth/Expansion | Minority | ||
| Shanghai Guotou Pioneer Private Equity Fund Management | Fund of Funds | Minority | ||
| Cedarlake Capital | PE/Buyout | Minority | ||
| GF Xinde Investment Management | PE/Buyout | Minority | ||
| Oriental Fortune Capital | Venture Capital | Minority |
Xellar Biosystems FAQs
-
When was Xellar Biosystems founded?
Xellar Biosystems was founded in 2021.
-
Where is Xellar Biosystems headquartered?
Xellar Biosystems is headquartered in Shanghai, China.
-
What is the size of Xellar Biosystems?
Xellar Biosystems has 21 total employees.
-
What industry is Xellar Biosystems in?
Xellar Biosystems’s primary industry is Discovery Tools (Healthcare).
-
Is Xellar Biosystems a private or public company?
Xellar Biosystems is a Private company.
-
What is Xellar Biosystems’s current revenue?
The current revenue for Xellar Biosystems is .
-
How much funding has Xellar Biosystems raised over time?
Xellar Biosystems has raised $82.3M.
-
Who are Xellar Biosystems’s investors?
Shanghai Guofang Private Equity Fund Management, Shanghai Guotou Pioneer Private Equity Fund Management, Cedarlake Capital, GF Xinde Investment Management, and Oriental Fortune Capital are 5 of 15 investors who have invested in Xellar Biosystems.
-
Who are Xellar Biosystems’s competitors?
Genesis Molecular AI, Asimov, Exscientia, A-Alpha Bio, and X-37 are some of the 39 competitors of Xellar Biosystems.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process